NCT03325036
Completed
Not Applicable
Serum Immunological Profiles in Head and Neck Cancer Patients Receiving Curative Radiotherapy: Quantitative Analysis and Prognostic Implication
ConditionsHead and Neck Cancers Patients
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Head and Neck Cancers Patients
- Sponsor
- National Taiwan University Hospital
- Enrollment
- 60
- Locations
- 1
- Primary Endpoint
- Disease progression
- Status
- Completed
- Last Updated
- 4 months ago
Overview
Brief Summary
The purpose of the study is to investigate the clinical usefulness of serum levels of immunologic profiles including pro/anti-inflammatory interleukins, other detectable serum biomarkers including transforming growth factor b1 (TGFb1) or soluble major histocompatibility complex Class I chain-related peptide A (sMICA), and leukocyte subpopulations in head and neck cancers patients receiving curative radiotherapy, as prognostic biomarkers for disease recurrence and survival.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Patients with head and neck cancer receiving curative radiotherapy in NTUH radiation therapy department.
Exclusion Criteria
- •Patients with head and neck cancer NOT receiving curative radiotherapy in NTUH radiation therapy department.
Outcomes
Primary Outcomes
Disease progression
Time Frame: Three years
Tumor local recurrence or distant metastasis
Study Sites (1)
Loading locations...
Similar Trials
Completed
Not Applicable
Biomarkers in Patients With Head and Neck Cancer and in Healthy VolunteersHead and Neck CancerNCT00899769Vanderbilt University Medical Center100
Recruiting
Not Applicable
Immune Biomarker Study for Head and Neck CancerHead and Neck CancerOral Cavity CancerOropharyngeal CancerHypopharyngeal CancerLaryngeal CancerNCT05375266University of Erlangen-Nürnberg Medical School1,100
Completed
Not Applicable
Observational Study on Biomarkers in Head and Neck Cancer (HNprädBio)Head and Neck CancerNCT02059668Technische Universität Dresden588
Completed
Not Applicable
Evaluation of Subcutaneous Immunotherapy Towards Pollen in ChildrenRhinitis, AllergicConjunctivitis, AllergicAsthmaNCT03375775Karolinska Institutet40
Withdrawn
Not Applicable
Predicting Immunotherapy Efficacy in Head and Neck Squamous Cell CancerHead and Neck Squamous Cell CarcinomaNCT05296135Cofactor Genomics, Inc.40